USVP

U.S. Venture Partners (USVP) is a prominent venture capital partnership dedicated to assisting entrepreneurs in turning their innovative ideas into impactful companies. With over thirty years of experience, the firm specializes in early-stage investments primarily within the information technology and healthcare sectors. USVP's investment focus includes enterprise software, IT security, consumer internet, mobile applications, e-commerce, and IT-enabled healthcare services. The team at USVP comprises former entrepreneurs, technologists, corporate leaders, financial experts, and industry specialists, all committed to fostering innovation that generates economic growth and job creation.

Dale Holladay

CFO

Jon Root

General Partner

559 past transactions

Surgical Safety Technologies delivers data-driven AI technology to hospitals for safe surgeries. It empowers surgeons with an objective assessment of technical and non-technical proficiency using academically validated frameworks.

TaskHuman

Series B in 2022
You go to a network of doctors for medical problems, but where do you go for wellness and self-care? Your wellness needs are just as unique as YOU are. Whether you are just a curious person and want to learn something new (Ex: Try Pilates for the first time) or want to master your craft (Train for a marathon at a high level), why waste time reading cookie-cutter articles and watching generic videos when you can talk live to a human expert in that area? Well, because even mighty Google hasn't made it that easy to find and engage instantly with live human pros!!. Introducing TaskHuman - With TaskHuman, you just search a topic (ex yoga, or HIIT or Clean Eating) and get connected instantly to live professionals over video call. You'll stay accountable, motivated and focused on your wellness goals all while saving time, commuting miles and cash. - On TaskHuman, every session is with a live human coach and 1-on-1 over video call, leading to a richer and more personalized experience, as opposed to other platforms that only offer generic content, pre-recorded videos and text-only communication.Or if you are shy or video call is simply not your thing, choose audio call or text instead. - Try a 1:1 yoga session with a yoga master or get personalized clean eating advice from top holistic health coaches. From just your phone or tablet!! - We've build in state-of-the-art artificial intelligence (AI) to instantly match you with our providers that are online and available NOW. - We also have the most diverse network of hundreds of coaches covering a thousand topics across the wellness spectrum—including physical fitness, mental wellbeing, relationship coaching, life coaching, and so much more. - With a revolutionary pricing model, all coaches are covered under one simple pricing model for you. Just buy coaching minutes you need and use the minutes on ANY provider in our platform. Its that easy! - Enterprise deployments with unlimited coaching minutes available as well!

MicroTransponder

Series E in 2022
MicroTransponder, Inc. is a medical device company focused on developing and commercializing neurostimulation devices aimed at treating neurological diseases. The company offers innovative therapies, including the Serenity System for tinnitus and the Paired VNS System, which addresses chronic pain and post-stroke upper limb mobility issues. Founded in 2007, MicroTransponder is headquartered in Dallas, Texas, and aims to enhance treatment options for various neurological conditions through its advanced technology.

nfinite

Series B in 2022
nfinite is a Paris-based company founded in 2016 that operates a web platform connecting homeowners, architects, and designers to facilitate home customization. The platform leverages artificial intelligence and proprietary 3D technology to enhance the visual experience for online home and living businesses. In addition to customization services, nfinite also offers a range of products for sale, aiming to streamline the process of designing and purchasing homes.

Carlsmed

Series B in 2022
Carlsmed, founded in 2018 and headquartered in San Diego, California, specializes in developing advanced solutions for the treatment of complex spinal deformities. The company utilizes artificial intelligence, predictive analytics, and advanced imaging technologies through its proprietary Aprevo platform. This platform enables surgeons to create personalized surgical plans and devices tailored to each patient's specific medical needs. By harnessing clinical intelligence and prior outcomes data, Carlsmed aims to improve surgical results while reducing healthcare costs associated with complex spine surgeries. The company's innovative approach is designed to enhance the ability of spine surgeons to achieve better outcomes, ultimately helping patients regain their active lifestyles.

IONIX

Series A in 2022
IONIX is an Israeli cybersecurity company founded in 2016, based in Tel Aviv. The company develops an ecosystem security platform designed to help organizations identify and mitigate threats associated with their online assets, which include websites and cloud services. Its primary product, HackerPOV, provides advanced security monitoring and mapping of assets, enabling users to analyze and audit their web, cloud, and DNS infrastructures. IONIX's solutions focus on discovering vulnerabilities, assessing risks, and offering protection against malicious activities originating from users and third parties. The platform also monitors changes that may impact security and provides detailed alerts and active protection to secure organizational assets effectively.

Kryptowire

Venture Round in 2022
Kryptowire was jumpstarted by the Defense Advanced Research Projects Agency (DARPA) and the Department of Homeland Security (DHS S&T), and has been vetted by the US military, law enforcement, and intelligence agencies. Kryptowire provides mobile application security analysis tools, anti‐piracy technologies, mobile app marketplace security analytics, and Enterprise Mobility Management (EMM) solutions. Kryptowire was founded in 2011, is based in Fairfax, Virginia, and has a customer base ranging from government agencies to national cable TV companies.

nfinite

Series A in 2022
nfinite is a Paris-based company founded in 2016 that operates a web platform connecting homeowners, architects, and designers to facilitate home customization. The platform leverages artificial intelligence and proprietary 3D technology to enhance the visual experience for online home and living businesses. In addition to customization services, nfinite also offers a range of products for sale, aiming to streamline the process of designing and purchasing homes.

Hunters

Series C in 2022
Hunters is a cybersecurity company based in Tel Aviv, Israel, founded in 2018. It specializes in developing an artificial intelligence-based software solution designed to detect and prevent cyberattacks. The company's flagship platform, Hunters.AI, autonomously identifies threats that may evade traditional security measures, enhancing threat detection and response across various IT environments, including cloud and network infrastructures. By ingesting extensive security telemetry and intelligence from diverse data sources, the platform enriches threat signals with detailed attack intelligence. It employs machine learning and cloud-based analytics to correlate threat patterns and generate actionable visualized attack narratives, ultimately optimizing response times for cybersecurity teams.

Qnovo

Series C in 2022
Qnovo Incorporated specializes in adaptive charging software for mobile devices, enhancing battery performance through innovative algorithms. Founded in 2009 and based in Newark, California, the company offers several products, including QNS, an adaptive charging solution for smartphones that allows for rapid charging while extending battery life to over 800 cycles. It also provides µQNS for two-in-one laptops and a solution for wearables that optimizes high energy-density batteries for fast charging and longevity. Additionally, Qnovo offers predictive analytics that help device manufacturers and mobile carriers gain insights into battery performance, ultimately reducing return costs. By continuously measuring battery health and adjusting charging parameters in real-time, Qnovo significantly improves the mobile user experience by enabling faster charging, longer daily usage, and enhanced overall battery lifespan.

Route 92

Series E in 2021
Route 92 Medical, Inc. specializes in developing innovative medical devices aimed at treating acute ischemic stroke and related conditions. The company has created a stealthy catheter, a rapid aspiration thrombectomy system, and an intra-cerebral implant delivery system. These products are designed to assist healthcare professionals in effectively treating strokes and enhancing patient recovery. Founded in 2015 and based in San Mateo, California, Route 92 Medical continues to focus on advancing technologies that improve outcomes for stroke patients.

TaskHuman

Series A in 2021
You go to a network of doctors for medical problems, but where do you go for wellness and self-care? Your wellness needs are just as unique as YOU are. Whether you are just a curious person and want to learn something new (Ex: Try Pilates for the first time) or want to master your craft (Train for a marathon at a high level), why waste time reading cookie-cutter articles and watching generic videos when you can talk live to a human expert in that area? Well, because even mighty Google hasn't made it that easy to find and engage instantly with live human pros!!. Introducing TaskHuman - With TaskHuman, you just search a topic (ex yoga, or HIIT or Clean Eating) and get connected instantly to live professionals over video call. You'll stay accountable, motivated and focused on your wellness goals all while saving time, commuting miles and cash. - On TaskHuman, every session is with a live human coach and 1-on-1 over video call, leading to a richer and more personalized experience, as opposed to other platforms that only offer generic content, pre-recorded videos and text-only communication.Or if you are shy or video call is simply not your thing, choose audio call or text instead. - Try a 1:1 yoga session with a yoga master or get personalized clean eating advice from top holistic health coaches. From just your phone or tablet!! - We've build in state-of-the-art artificial intelligence (AI) to instantly match you with our providers that are online and available NOW. - We also have the most diverse network of hundreds of coaches covering a thousand topics across the wellness spectrum—including physical fitness, mental wellbeing, relationship coaching, life coaching, and so much more. - With a revolutionary pricing model, all coaches are covered under one simple pricing model for you. Just buy coaching minutes you need and use the minutes on ANY provider in our platform. Its that easy! - Enterprise deployments with unlimited coaching minutes available as well!

Luma Health

Series C in 2021
Luma Health Inc. is a San Francisco-based company that develops a patient engagement platform aimed at facilitating communication between healthcare providers and patients. Founded in 2015, the platform is designed to help healthcare systems and clinics efficiently manage patient appointments, including smart scheduling and referral management. It also offers features such as appointment reminders, mobile patient intake, care pathways, and EHR integrations, alongside analytics and insights. By connecting patients to care quickly and ensuring adherence to treatment plans, Luma Health enhances the overall patient experience and helps healthcare providers maintain a full schedule while improving treatment procedures.
Effector Therapeutics is a biotechnology company based in San Diego, California, that specializes in the development of small molecule drugs aimed at treating cancer and other serious diseases. Founded in 2012, the company focuses on creating selective translation regulators that target the regulation of protein synthesis, a critical process in tumor growth and survival. By selectively blocking dysregulated translation, Effector Therapeutics aims to inhibit cancer cell proliferation while providing a potent and targeted therapeutic approach. This innovative strategy positions the company to potentially deliver new and effective treatments to patients facing challenging health conditions.

Hunters

Series B in 2021
Hunters is a cybersecurity company based in Tel Aviv, Israel, founded in 2018. It specializes in developing an artificial intelligence-based software solution designed to detect and prevent cyberattacks. The company's flagship platform, Hunters.AI, autonomously identifies threats that may evade traditional security measures, enhancing threat detection and response across various IT environments, including cloud and network infrastructures. By ingesting extensive security telemetry and intelligence from diverse data sources, the platform enriches threat signals with detailed attack intelligence. It employs machine learning and cloud-based analytics to correlate threat patterns and generate actionable visualized attack narratives, ultimately optimizing response times for cybersecurity teams.

Carrot Fertility

Series C in 2021
Carrot Fertility, Inc. provides comprehensive fertility benefits services to employers, supporting employees throughout their fertility healthcare journey globally. Founded in 2015 and headquartered in San Francisco, the company offers a range of services, including egg freezing, in vitro fertilization, adoption, donor, and gestational carrier services. Additionally, it features Carrot Rx, which facilitates a premium pharmacy experience for fertility medications, and Carrot Pregnancy, providing virtual access to experts and on-demand content. Carrot Card is a flexible benefits debit card that allows employees to pay for their care. By partnering with modern companies, Carrot Fertility enables organizations to customize fertility benefits that deliver financial, medical, and emotional support to employees seeking to become parents. The company also has offices in major cities around the world, including Chicago, New York, Dublin, Geneva, Tokyo, and Seoul.

Human Interest

Series D in 2021
Human Interest provides accessible and affordable employee retirement plans, addressing a significant gap in the market where traditionally only large companies offered such benefits. This leaves over half of working Americans without a secure financial future. The company operates an administration and advising platform that automatically creates employee accounts and syncs deductions with payroll providers. Additionally, Human Interest offers personalized investment advice to empower small and medium-sized businesses in providing their employees with essential financial security. By democratizing access to retirement planning, Human Interest aims to foster financial independence for individuals across diverse occupations.

Ribon Therapeutics

Series C in 2021
Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, founded in 2015. The company is focused on developing innovative cancer therapies that target monoPARP proteins, which are essential regulators of cancer cell survival. Ribon's scientific founders have made significant contributions to the understanding of PARPs, or poly(ADP-ribose) polymerases, and their roles in cancer. Leveraging this expertise, Ribon is establishing a proprietary drug discovery platform aimed at exploring the molecular actions and biological functions of monoPARPs. This platform supports the creation of a pipeline of therapeutics that selectively target these proteins to potentially treat cancer and other diseases. Ribon Therapeutics is supported by notable life science investors, enhancing its capability to advance its research and development efforts.

Standard Bariatrics

Series B in 2021
Standard Bariatrics is a medical device company based in Cincinnati, Ohio, founded in 2014. The company specializes in the development of surgical instruments designed for weight loss surgeries, particularly laparoscopic sleeve gastrectomy. One of its key products is the Standard Clamp, which assists surgeons in standardizing their techniques to minimize variation, enhance efficiency, and reduce waste during procedures. Additionally, the company's disposable surgical tools complement general-use endoscopic staplers, allowing surgeons to decrease the number of cartridges used in surgeries and ultimately lowering costs. Through these innovations, Standard Bariatrics aims to improve surgical outcomes and streamline the weight loss surgery process.

Oliver Space

Series A in 2021
Oliver Space is a home furnishing company founded in 2019 and based in San Francisco, California. It operates an online platform that provides a diverse selection of furniture and home decor products, including sofas, rugs, pillows, and plants. Customers can access these items through a monthly subscription model, which offers flexible rent or buy options. This approach allows individuals to easily and affordably create beautiful living spaces, while also benefiting from free design assistance.

Sparrow Pharmaceuticals

Series A in 2021
Sparrow Pharmaceuticals, founded in 2013 and based in Portland, Oregon, focuses on developing targeted therapies for conditions related to corticosteroid excess. The company aims to provide innovative treatment options for disorders linked to elevated levels of cortisol, which can arise from tumors or prolonged use of corticosteroid medications like prednisone. By addressing serious issues associated with hypercortisolism, Sparrow Pharmaceuticals seeks to enhance the management of autoimmune and inflammatory conditions, ultimately improving patient care and outcomes in this challenging medical area.

Informed

Series A in 2021
Informed helps banks accelerate their digital transformation with turn-key robotic process automation capable of performing real-time income verification, identity verification, residence verification, and insurance verification tasks. Banks use Informed to reduce their manual costs associated with reviewing documents, catch fraud, and cut down on errors when originating loans and opening accounts.

AirEye

Series A in 2021
Developer of a wireless security policy designed to control and protect corporate network airspace. The company's platform offers complete visibility, control, and immediate protection for all wireless activity occurring within network airspace, including employee hotspots, shadow networks, dual-connected devices, and other users' wireless devices that infiltrate the corporate network, it delivers pioneering AI-driven, agent-less security for all IT and OT assets, individually protecting each and every Wi-Fi-enabled asset, enabling clients to stop unauthorized users from accessing their networks, causing data leaks, and stealing user identities.

Territory Foods

Series B in 2021
Territory Foods is a meal delivery service that focuses on providing chef-prepared, nutritionist-approved meals tailored to various dietary preferences. Established in 2011 and headquartered in Arlington, VA, the company offers a diverse range of freshly-made meals designed by culinary professionals and nutrition experts. Its menus feature artisan dishes that are responsibly sourced and free of refined sugars, gluten, and dairy, catering to health-conscious consumers. Meals can be customized to fit dietary needs such as Vegan, Vegetarian, Whole30, and Keto, making it easier for customers to maintain healthy eating habits. Territory Foods employs a proprietary algorithm to ensure a rotating menu that keeps meal options varied and engaging.

Dapper Labs

Venture Round in 2021
Dapper Labs Inc., based in Vancouver, Canada, is a developer of blockchain-based video games and digital collectibles. Founded in 2018, the company is known for its consumer-focused Flow blockchain platform, which supports the creation and distribution of non-fungible tokens (NFTs) and other digital assets. Dapper Labs aims to enhance digital engagement by allowing fans to interact with their favorite brands in innovative ways. Through its platform, users can securely track ownership of unique digital items while also having the opportunity to create their own content. This approach not only entertains but also fosters a decentralized environment where value is placed on digital collectibles and user-generated creations.

Act-On Software

Venture Round in 2021
Act-On Software, Inc. is a provider of a cloud-based marketing automation platform tailored for small and mid-sized businesses. The platform enables marketers to create and manage effective marketing campaigns through a range of tools including email marketing, website lead generation, social media marketing, and marketing analytics. It focuses on enhancing customer experiences and driving demand, while also facilitating brand awareness and customer retention. In addition to its software solutions, Act-On offers professional consulting, support, and training services to help clients maximize their marketing efforts. The company serves diverse sectors including banking, insurance, manufacturing, and technology, and operates from its headquarters in Portland, Oregon, with additional locations in Scottsdale, Arizona, and Reading, United Kingdom. Act-On Software was originally known as On-Demand Software, Inc. before rebranding in June 2006.

Badge

Venture Round in 2021
Developer of a unified authentication tool designed to provide identity management. The company's tool uses lattice-based cryptography to store a person's identity, enabling users to own their keys and identity and not rely on any company or government to protect their data.

Neuros Medical

Series B in 2021
Neuros Medical, Inc. is a neuromodulation company based in Willoughby Hills, Ohio, that specializes in developing proprietary neurostimulation therapies to address unmet medical needs for patients globally. The company’s flagship technology, Electrical Nerve Block, targets the elimination of chronic pain associated with various conditions, including neuroma, residual limb pain, chronic post-surgical pain, and chronic migraines. Additionally, Neuros Medical offers the Neuros Altius System, which features an implantable generator with an integrated rechargeable battery, a cuff electrode, and external devices designed to enhance treatment outcomes. Founded in 2008, the company aims to provide innovative solutions for chronic pain management.

Carlsmed

Series A in 2020
Carlsmed, founded in 2018 and headquartered in San Diego, California, specializes in developing advanced solutions for the treatment of complex spinal deformities. The company utilizes artificial intelligence, predictive analytics, and advanced imaging technologies through its proprietary Aprevo platform. This platform enables surgeons to create personalized surgical plans and devices tailored to each patient's specific medical needs. By harnessing clinical intelligence and prior outcomes data, Carlsmed aims to improve surgical results while reducing healthcare costs associated with complex spine surgeries. The company's innovative approach is designed to enhance the ability of spine surgeons to achieve better outcomes, ultimately helping patients regain their active lifestyles.

Edgewise Therapeutics

Series C in 2020
Edgewise Therapeutics is a clinical-stage biopharmaceutical company based in Boulder, Colorado, specializing in the development of small molecule therapies for severe musculoskeletal diseases. Founded in 2017, the company leverages its expertise in skeletal muscle physiology to create innovative treatments for genetically defined muscle disorders, including Duchenne, Becker, and limb girdle muscular dystrophies. Edgewise Therapeutics employs a precision medicine platform to identify and target key muscle proteins and modulators, aiming to address the underlying causes of these conditions. Additionally, the company has established a state-of-the-art research facility to enhance its capabilities in understanding muscle adaptation and injury related to disease.

Percepto

Series B in 2020
Percepto is a developer of autonomous drone technology for inspection and surveillance. Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier to making them a must-have platform is the ability of drones to perform tasks autonomously. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Stensul

Series B in 2020
Stensul, Inc. is a New York-based company that offers a hosted Software-as-a-Service (SaaS) email creation platform designed for enterprises and large organizations globally. Founded in 2016, the platform enables users to efficiently create and deliver mobile-responsive emails for various purposes, such as email-based customer relationship management and marketing automation. By streamlining the email creation process and reducing the reliance on designers and developers, Stensul allows marketers to concentrate on producing engaging content that drives results. The platform is centralized, scalable, and tailored to individual brands, facilitating the quick generation of emails that can be sent directly through users' existing email service providers or marketing clouds.

Shoulder Innovations

Venture Round in 2020
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed a Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical challenge of reliable fixation for glenoid implants. This technology not only enhances post-surgical implant stability, reducing the risk of revision surgeries, but also simplifies surgical instrumentation, which can lead to shorter operative times and lower costs. Shoulder Innovations markets its products through distribution partners across the United States, aiming to improve patient care and reduce overall healthcare costs.

Silverback Therapeutics

Series C in 2020
Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing tissue-targeted therapeutics for cancer, chronic viral infections, and other serious diseases. The company's lead product candidate, SBT6050, is currently in a Phase I/Ib clinical trial. It is a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody, specifically targeting tumors such as breast, gastric, and non-small cell lung cancers. Additionally, Silverback is advancing SBT6290, a preclinical candidate that targets Nectin4, expressed in various cancers, and SBT8230, aimed at treating chronic hepatitis B virus infection. Utilizing its proprietary ImmunoTAC technology, Silverback aims to develop a new generation of therapies that can be systemically delivered yet act locally at disease sites, thereby modulating critical disease pathways that were previously considered inaccessible.

Medigate

Series B in 2020
Medigate owns and operates a medical device security platform that protects all connected medical devices on health care provider networks. The platform offers threat detection and attack prevention services. Itay Kirshenbaum, Jonathan Langer, and Pini Pinhasov founded Medigate on September 1, 2017. It has its headquarters in New York City.

Optimize Health

Series A in 2020
Optimize Health is a Seattle-based company that offers a digital healthcare platform focused on Remote Patient Monitoring (RPM) for outpatient medical practices. Founded in 2015, it provides software, equipment, and services designed to enhance patient engagement and compliance with new Medicare billing codes. Its platform simplifies the management of RPM programs by automatically tracking medication doses and sending reminders to patients through Bluetooth-enabled devices. This user-friendly approach aims to improve the experience for both patients and healthcare providers while enabling physicians to achieve profitability from the first month of implementation. The company’s offerings include a clinical call center and various support services to ensure effective patient monitoring.

Carrot Fertility

Series B in 2020
Carrot Fertility, Inc. provides comprehensive fertility benefits services to employers, supporting employees throughout their fertility healthcare journey globally. Founded in 2015 and headquartered in San Francisco, the company offers a range of services, including egg freezing, in vitro fertilization, adoption, donor, and gestational carrier services. Additionally, it features Carrot Rx, which facilitates a premium pharmacy experience for fertility medications, and Carrot Pregnancy, providing virtual access to experts and on-demand content. Carrot Card is a flexible benefits debit card that allows employees to pay for their care. By partnering with modern companies, Carrot Fertility enables organizations to customize fertility benefits that deliver financial, medical, and emotional support to employees seeking to become parents. The company also has offices in major cities around the world, including Chicago, New York, Dublin, Geneva, Tokyo, and Seoul.

Hunters

Series A in 2020
Hunters is a cybersecurity company based in Tel Aviv, Israel, founded in 2018. It specializes in developing an artificial intelligence-based software solution designed to detect and prevent cyberattacks. The company's flagship platform, Hunters.AI, autonomously identifies threats that may evade traditional security measures, enhancing threat detection and response across various IT environments, including cloud and network infrastructures. By ingesting extensive security telemetry and intelligence from diverse data sources, the platform enriches threat signals with detailed attack intelligence. It employs machine learning and cloud-based analytics to correlate threat patterns and generate actionable visualized attack narratives, ultimately optimizing response times for cybersecurity teams.

Okami Medical

Series D in 2020
Okami Medical, Inc. specializes in the manufacturing and supply of medical devices designed for the occlusion of peripheral vessels. The company's flagship product, the LOw-profile Braided Occluder (LOBO), provides interventional physicians with a versatile solution for occluding various arterial targets without the need for multiple embolic devices. The LOBO system features a patented design and proprietary HDBRAID technology, which creates a highly occlusive pore structure that effectively reduces blood flow and accelerates vessel closure. Founded in 2011 and headquartered in Aliso Viejo, California, Okami Medical was established to meet the evolving needs of patients and physicians by developing innovative and reliable medical devices for vessel occlusion.

Zerto

Series F in 2020
Zerto Ltd. specializes in disaster recovery and business continuity software tailored for virtualized data centers and cloud environments. The company's core offering, the Zerto Cloud Continuity Platform, includes Zerto Virtual Replication, which facilitates the protection, recovery, and migration of applications across various cloud settings, including public, private, and hybrid clouds. Zerto's products support critical applications such as Oracle, SAP, and SQL Server, ensuring uninterrupted operations for clients across diverse sectors, including healthcare, legal, and finance. Founded in 2009 and headquartered in Herzliya, Israel, Zerto also maintains offices in key locations worldwide, including Boston, Shinjuku, Reading, Mumbai, and several areas in Canada and Latin America.

Cato Networks

Series D in 2020
Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform, designed to offer secure, scalable connectivity for modern enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, the company delivers an integrated networking and security solution that connects various enterprise locations, users, and data. Its offerings include software-defined wide area networking (SD-WAN), WAN optimization, firewall services, secure web gateways, and threat protection. Cato's platform enables organizations to reduce costs associated with traditional MPLS networks, improve performance across global locations, and ensure secure internet access for mobile users and cloud applications. By converging networking and security into a cloud-native service, Cato Networks helps businesses streamline operations and enhance security in a distributed, mobile, and cloud-enabled environment. The company also has a presence in key global locations, including the United States, the United Kingdom, Singapore, Hong Kong, and Australia.

Forager

Series A in 2020
Forager Group, Inc. is a company that specializes in cross-border freight and logistics services, primarily catering to supply chain networks in the automotive and aerospace sectors. Established in 2018 and headquartered in Chicago, Illinois, Forager offers a range of services, including standard, expedited, and cross-border truckload solutions. The company utilizes advanced technology to address the challenges faced by cross-border shippers, providing modern and efficient transportation solutions. Additionally, Forager features a user-friendly web-based transportation management platform that enhances service delivery in the logistics industry. Its operations extend throughout the United States, Mexico, and Canada.

Arkose Labs

Series B in 2020
Arkose Labs, Inc. is a technology company specializing in online fraud and abuse prevention for various sectors, including online marketplaces, travel, banking, social media, ticketing, and online gaming. Founded in 2015 and headquartered in San Francisco, California, with an additional location in Brisbane, Australia, the company offers a platform that safeguards consumer actions against threats such as account takeover, fake account abuse, scraping, spam, and gift card fraud. Arkose Labs employs a unique approach that focuses on determining true user intent and addressing attacks in real-time through risk assessments and interactive authentication challenges. By undermining the financial incentives behind fraudulent activities, the platform enhances security and improves customer experiences for businesses in retail, gaming, and fintech industries. Recognized by Gartner as a 2020 Cool Vendor, Arkose Labs aims to provide long-term protection while maintaining effective customer throughput.

Silverback Therapeutics

Series B in 2020
Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing tissue-targeted therapeutics for cancer, chronic viral infections, and other serious diseases. The company's lead product candidate, SBT6050, is currently in a Phase I/Ib clinical trial. It is a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody, specifically targeting tumors such as breast, gastric, and non-small cell lung cancers. Additionally, Silverback is advancing SBT6290, a preclinical candidate that targets Nectin4, expressed in various cancers, and SBT8230, aimed at treating chronic hepatitis B virus infection. Utilizing its proprietary ImmunoTAC technology, Silverback aims to develop a new generation of therapies that can be systemically delivered yet act locally at disease sites, thereby modulating critical disease pathways that were previously considered inaccessible.

HealthJoy

Series C in 2020
HealthJoy, LLC operates an innovative online healthcare decision platform aimed at helping consumers minimize out-of-pocket expenses through informed choices. Founded in 2014 and based in Chicago, Illinois, HealthJoy integrates existing employee benefits into a personalized digital wallet, enhancing engagement and understanding of healthcare options. By utilizing advanced artificial intelligence and virtual assistants, the platform guides users toward cost-effective care and provides access to a range of services, including online medical consultations, healthcare concierges, and prescription savings. This approach not only improves employee satisfaction but also enables organizations to contain costs and reduce HR inquiries, ultimately promoting educated healthcare shopping and simplifying the overall healthcare experience.

Epsagon

Series A in 2020
Epsagon Ltd. is a developer of solutions designed for monitoring serverless architecture systems. Founded in 2017 and headquartered in Tel Aviv, Israel, the company provides a SaaS platform that enables development and operations teams to enhance their efficiency by automating data correlation and offering end-to-end observability within microservice environments. Epsagon's lightweight agent SDK allows for automated instrumentation and tracing, ensuring comprehensive visibility across various cloud resources, including containers and virtual machines, without requiring extensive training or manual coding. By predicting performance issues before they arise and facilitating quicker problem resolution, Epsagon helps organizations optimize costs and reduce application downtime, ultimately streamlining the deployment of new features and improving overall operational effectiveness.

ShiraTronics

Series A in 2019
ShiraTronics is in the early stages of developing new innovative therapies to combat debilitating migraine headaches. The company is focused on commercializing novel neuromodulation technologies to treat this large unmet clinical need for patients and physicians. ShiraTronics is the first spinout from NuXcel a global medical device accelerator company.

Kenna Security

Series D in 2019
Kenna Security, Inc. is a technology company specializing in vulnerability management and risk intelligence solutions. Founded in 2009 and headquartered in San Francisco, with an additional office in Chicago, the company offers the Kenna platform, which enables organizations to prioritize vulnerabilities, measure risk, and automate analysis. By utilizing Cyber Risk Context Technology, Kenna helps clients focus on critical cyber risks, thereby enhancing the efficiency of security teams. Its solutions cater to a diverse range of sectors, including media and entertainment, healthcare, telecommunications, financial services, and more, both domestically and internationally. Kenna Security has established itself as a leader in predictive cyber risk management, serving numerous Fortune 100 companies across various industries.

Primary

Series C in 2019
Primary is making better clothes for kids and building a better experience for busy parents to shop for them. It aims to be the most inclusive kid's clothing brand, offering high-quality essentials at affordable prices. Rather than chasing the trend, Primary offers thoughtfully designed clothing without logos, slogans, or sequins. They take a gender-neutral approach, with a broad range of colors available for babies and kids 0-12, without prescribing what is for girls or boys. It was founded in 2015 and is headquartered in New York, New York.

Edgewise Therapeutics

Series B in 2019
Edgewise Therapeutics is a clinical-stage biopharmaceutical company based in Boulder, Colorado, specializing in the development of small molecule therapies for severe musculoskeletal diseases. Founded in 2017, the company leverages its expertise in skeletal muscle physiology to create innovative treatments for genetically defined muscle disorders, including Duchenne, Becker, and limb girdle muscular dystrophies. Edgewise Therapeutics employs a precision medicine platform to identify and target key muscle proteins and modulators, aiming to address the underlying causes of these conditions. Additionally, the company has established a state-of-the-art research facility to enhance its capabilities in understanding muscle adaptation and injury related to disease.

Luma Health

Series B in 2019
Luma Health Inc. is a San Francisco-based company that develops a patient engagement platform aimed at facilitating communication between healthcare providers and patients. Founded in 2015, the platform is designed to help healthcare systems and clinics efficiently manage patient appointments, including smart scheduling and referral management. It also offers features such as appointment reminders, mobile patient intake, care pathways, and EHR integrations, alongside analytics and insights. By connecting patients to care quickly and ensuring adherence to treatment plans, Luma Health enhances the overall patient experience and helps healthcare providers maintain a full schedule while improving treatment procedures.

Entelo

Venture Round in 2019
Entelo applies intelligence to big data to help modern recruiters find, qualify, and acquire talent. Today over 600 customers of all sizes and industries trust Entelo to provide their talent acquisition teams with higher candidate engagement, actionable insights, and increased productivity. To learn how leading companies such as Capital One, Cisco, Facebook, GE, Genentech, Netflix, Northrop Grumman, and Target are building their organizations using Entelo, visit www.entelo.com.

Rimeto

Series A in 2019
Rimeto LLC, founded in 2016 and based in San Francisco, California, specializes in developing application and system software that enhances workplace collaboration through detailed employee directories and profiles. The company aims to improve access to information within organizations, enabling employees to connect more effectively with their colleagues and tap into collective knowledge. Rimeto's platform integrates data from various enterprise systems, creating a custom-built directory that consolidates information about people, projects, and teams. By leveraging both public and proprietary data sets, Rimeto provides clients with a powerful tool that enhances organizational transparency and facilitates better communication and collaboration, ultimately fostering a more connected work environment. As of June 2020, Rimeto operates as a subsidiary of Slack Technologies.

Human Interest

Series B in 2019
Human Interest provides accessible and affordable employee retirement plans, addressing a significant gap in the market where traditionally only large companies offered such benefits. This leaves over half of working Americans without a secure financial future. The company operates an administration and advising platform that automatically creates employee accounts and syncs deductions with payroll providers. Additionally, Human Interest offers personalized investment advice to empower small and medium-sized businesses in providing their employees with essential financial security. By democratizing access to retirement planning, Human Interest aims to foster financial independence for individuals across diverse occupations.

Cleave Therapeutics

Series C in 2019
Cleave Therapeutics, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2010. The company specializes in developing novel small-molecule drugs that target valosin-containing protein and other protein-degradation pathways critical for the survival of cancer cells. By focusing on these mechanisms, Cleave Therapeutics aims to create enzyme inhibitors that can effectively treat cancer and neurodegenerative diseases. Its research efforts are directed toward discovering innovative therapies that may improve patient outcomes in oncology.

Omada

Series D in 2019
Omada Health, Inc. is a digital healthcare company that creates online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health helps employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the needs of participants, including services for diabetes prevention and management, hypertension, behavioral health, and musculoskeletal issues. By integrating professional health coaching, connected devices, real-time data, and personalized feedback, Omada Health strives to empower individuals to engage with their health and achieve sustainable lifestyle changes. It is recognized as the largest provider of the National Diabetes Prevention Program by the CDC.

Dstillery

Series D in 2019
Dstillery, Inc. is a digital intelligence platform that specializes in custom audience solutions for brands and their media partners. Founded in 2008 and based in New York, the company offers a range of marketing solutions designed to enhance brand awareness, consideration, and customer retention. Dstillery's premier product, Custom AI Audiences, utilizes tailored artificial intelligence models to deliver accurate and scalable audience targeting. The platform integrates mobile location insights with desktop behaviors, optimizing marketing efforts across various channels, including mobile, desktop, and video. Dstillery also provides geospatial insights through its Dscover Maps tool, allowing brands to analyze market composition by geography. The company serves a diverse clientele across multiple sectors, including retail, finance, and technology, helping them leverage customer data to drive revenue growth and improve audience engagement.

Percepto

Series A in 2019
Percepto is a developer of autonomous drone technology for inspection and surveillance. Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier to making them a must-have platform is the ability of drones to perform tasks autonomously. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Happy Returns

Venture Round in 2019
Happy Returns, Inc. specializes in facilitating in-person returns for online shoppers through a nationwide network of Return Bar locations. Founded in 2015 and headquartered in Santa Monica, California, the company offers a seamless return experience by allowing customers to return items in person and receive immediate refunds, while managing the logistics of shipping returned items back to e-commerce retailers. Happy Returns provides retailers with a Full Stack Returns solution that includes branded online return processes and multiple return options, such as in-store returns and carrier pickups. The company emphasizes efficiency and cost-effectiveness, aiming to enhance customer satisfaction through its integrated technology and logistics services, which have garnered a high Net Promoter Score. Happy Returns has attracted investment from notable firms, including PayPal and Upfront Ventures.

HealthJoy

Series B in 2019
HealthJoy, LLC operates an innovative online healthcare decision platform aimed at helping consumers minimize out-of-pocket expenses through informed choices. Founded in 2014 and based in Chicago, Illinois, HealthJoy integrates existing employee benefits into a personalized digital wallet, enhancing engagement and understanding of healthcare options. By utilizing advanced artificial intelligence and virtual assistants, the platform guides users toward cost-effective care and provides access to a range of services, including online medical consultations, healthcare concierges, and prescription savings. This approach not only improves employee satisfaction but also enables organizations to contain costs and reduce HR inquiries, ultimately promoting educated healthcare shopping and simplifying the overall healthcare experience.

Nuvaira

Series E in 2019
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Medigate

Series A in 2019
Medigate owns and operates a medical device security platform that protects all connected medical devices on health care provider networks. The platform offers threat detection and attack prevention services. Itay Kirshenbaum, Jonathan Langer, and Pini Pinhasov founded Medigate on September 1, 2017. It has its headquarters in New York City.

Cato Networks

Series C in 2019
Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform, designed to offer secure, scalable connectivity for modern enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, the company delivers an integrated networking and security solution that connects various enterprise locations, users, and data. Its offerings include software-defined wide area networking (SD-WAN), WAN optimization, firewall services, secure web gateways, and threat protection. Cato's platform enables organizations to reduce costs associated with traditional MPLS networks, improve performance across global locations, and ensure secure internet access for mobile users and cloud applications. By converging networking and security into a cloud-native service, Cato Networks helps businesses streamline operations and enhance security in a distributed, mobile, and cloud-enabled environment. The company also has a presence in key global locations, including the United States, the United Kingdom, Singapore, Hong Kong, and Australia.

HighLife

Series B in 2019
HighLife SAS is a medtech company that specializes in developing a novel transcatheter mitral valve replacement system aimed at treating patients with mitral regurgitation. Founded in 2010 and headquartered in Paris, France, with an additional office in Irvine, California, the company focuses on providing a minimally invasive prosthetic mitral valve that can be implanted on a beating heart. This approach preserves the native valve structure and respects the surrounding anatomy, ensuring reduced trauma during surgical procedures. HighLife's technology is designed for ease and safety of use, as well as optimal treatment outcomes, allowing for delivery through a transseptal passage via the femoral vein. The system is currently undergoing clinical evaluation to assess its effectiveness in addressing severe heart conditions.

Ribon Therapeutics

Series B in 2019
Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, founded in 2015. The company is focused on developing innovative cancer therapies that target monoPARP proteins, which are essential regulators of cancer cell survival. Ribon's scientific founders have made significant contributions to the understanding of PARPs, or poly(ADP-ribose) polymerases, and their roles in cancer. Leveraging this expertise, Ribon is establishing a proprietary drug discovery platform aimed at exploring the molecular actions and biological functions of monoPARPs. This platform supports the creation of a pipeline of therapeutics that selectively target these proteins to potentially treat cancer and other diseases. Ribon Therapeutics is supported by notable life science investors, enhancing its capability to advance its research and development efforts.

NeoChord

Series D in 2018
NeoChord, Inc. is a medical technology company that specializes in developing devices to address degenerative mitral valve disease (DMR), a condition that can lead to serious complications such as atrial fibrillation and congestive heart failure. The company's flagship product is the NeoChord Artificial Chordae Delivery System, a disposable device designed to repair damaged heart chordae through a small incision while the heart continues to beat. This innovative approach allows for mitral valve repair to be performed via a 2 to 3-inch incision between the ribs, significantly less invasive than traditional methods that require larger incisions and the use of heart-lung machines. Founded in 2007, NeoChord is headquartered in St. Louis Park, Minnesota.

ZypMedia

Series C in 2018
Zypmedia provides local ad sales executives and their customers an opportunity to grow their business and evolve with a changing media environment. ZypMedia is a full-stack digital advertising technology platform that combines the power of machine learning with the intelligence of human experts to specialize in local-focused advertising. The company's innovative, intelligent tools enable you to bridge the audience gap between traditional and digital worlds, expand your offerings to better reach your local audience, and significantly grow your revenue.

Arkose Labs

Series A in 2018
Arkose Labs, Inc. is a technology company specializing in online fraud and abuse prevention for various sectors, including online marketplaces, travel, banking, social media, ticketing, and online gaming. Founded in 2015 and headquartered in San Francisco, California, with an additional location in Brisbane, Australia, the company offers a platform that safeguards consumer actions against threats such as account takeover, fake account abuse, scraping, spam, and gift card fraud. Arkose Labs employs a unique approach that focuses on determining true user intent and addressing attacks in real-time through risk assessments and interactive authentication challenges. By undermining the financial incentives behind fraudulent activities, the platform enhances security and improves customer experiences for businesses in retail, gaming, and fintech industries. Recognized by Gartner as a 2020 Cool Vendor, Arkose Labs aims to provide long-term protection while maintaining effective customer throughput.

Raken

Series A in 2018
Raken, Inc. develops a construction management software that enhances field and office workflows for the construction industry. Founded in 2012 and based in Carlsbad, California, Raken offers a mobile-first platform that includes features such as daily reports, time cards, production tracking, and toolbox talks. This software enables general, trade, concrete, electrical, excavating, and mechanical contractors to efficiently manage various construction-related tasks, including accident documentation, subcontractor information, site safety, project photos, weather conditions, and equipment rentals. Raken's technology streamlines communication between the field and office, allowing superintendents, foremen, and project managers to quickly record and submit essential reports and documentation. The platform is utilized by numerous leading contractors and subcontractors in the industry.

Luma Health

Series A in 2018
Luma Health Inc. is a San Francisco-based company that develops a patient engagement platform aimed at facilitating communication between healthcare providers and patients. Founded in 2015, the platform is designed to help healthcare systems and clinics efficiently manage patient appointments, including smart scheduling and referral management. It also offers features such as appointment reminders, mobile patient intake, care pathways, and EHR integrations, alongside analytics and insights. By connecting patients to care quickly and ensuring adherence to treatment plans, Luma Health enhances the overall patient experience and helps healthcare providers maintain a full schedule while improving treatment procedures.

Inari Medical

Series C in 2018
Inari Medical is a commercial-stage medical device company headquartered in Irvine, California, established in 2011. The company specializes in developing innovative products for the treatment of venous diseases, particularly focusing on venous thromboembolism. Inari Medical has created two key minimally invasive devices: the ClotTriever, designed for the removal of blood clots from peripheral blood vessels in patients with deep vein thrombosis, and the FlowTriever, which is used to treat pulmonary embolism. Both systems are 510(k)-cleared by the FDA, allowing for effective clot removal without the need for thrombolytic drugs. Inari Medical aims to enhance the quality of life for patients suffering from these conditions, with the majority of its revenue generated from the United States and additional contributions from international markets.

Kenna Security

Series C in 2018
Kenna Security, Inc. is a technology company specializing in vulnerability management and risk intelligence solutions. Founded in 2009 and headquartered in San Francisco, with an additional office in Chicago, the company offers the Kenna platform, which enables organizations to prioritize vulnerabilities, measure risk, and automate analysis. By utilizing Cyber Risk Context Technology, Kenna helps clients focus on critical cyber risks, thereby enhancing the efficiency of security teams. Its solutions cater to a diverse range of sectors, including media and entertainment, healthcare, telecommunications, financial services, and more, both domestically and internationally. Kenna Security has established itself as a leader in predictive cyber risk management, serving numerous Fortune 100 companies across various industries.

Luminate Security

Series A in 2018
Luminate Security Ltd. operates a software-as-a-service security platform designed to enable secure access management for corporate resources from any device. Founded in 2016 and based in Tel Aviv, Israel, Luminate supports the implementation of a Zero Trust Application Access architecture, allowing IT teams to connect users to corporate applications while minimizing the attack surface and enhancing visibility and compliance. The platform integrates seamlessly with cloud infrastructure and on-premises data center technologies, employing Software-Defined Perimeter principles to ensure resources remain hidden from public access. Access is granted through a trust broker, where users undergo authentication and authorization prior to application usage. The agentless Luminate Secure Access Cloud can be deployed in under five minutes, providing comprehensive visibility of user actions and facilitating governance and risk mitigation for corporate resources. As of February 2019, Luminate Security operates as a subsidiary of NortonLifeLock Inc.

Intuity Medical

Debt Financing in 2018
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution for millions of patients who need to regularly test their blood glucose. The company was founded in 2002 and is headquartered in Fremont, California.

Happy Returns

Series B in 2017
Happy Returns, Inc. specializes in facilitating in-person returns for online shoppers through a nationwide network of Return Bar locations. Founded in 2015 and headquartered in Santa Monica, California, the company offers a seamless return experience by allowing customers to return items in person and receive immediate refunds, while managing the logistics of shipping returned items back to e-commerce retailers. Happy Returns provides retailers with a Full Stack Returns solution that includes branded online return processes and multiple return options, such as in-store returns and carrier pickups. The company emphasizes efficiency and cost-effectiveness, aiming to enhance customer satisfaction through its integrated technology and logistics services, which have garnered a high Net Promoter Score. Happy Returns has attracted investment from notable firms, including PayPal and Upfront Ventures.

Imperva

Series B in 2017
Imperva, Inc. is a cybersecurity company that specializes in protecting critical business data and applications across cloud and on-premises environments. Founded in 2002 and headquartered in Redwood Shores, California, Imperva offers a comprehensive suite of security solutions, including its SecureSphere product line, which provides database, file, and web application security. The company also offers services like Incapsula for cloud-based website security and distributed denial-of-service protection. Other notable products include ThreatRadar, which delivers security intelligence, CounterBreach for safeguarding data from internal threats, and Camouflage Data Masking for creating functional data while protecting sensitive information. Imperva serves a diverse clientele, including banks, retailers, insurers, technology firms, and government agencies, through a network of distributors and resellers, ensuring visibility and control over high-value business data.

Neuros Medical

Series A in 2017
Neuros Medical, Inc. is a neuromodulation company based in Willoughby Hills, Ohio, that specializes in developing proprietary neurostimulation therapies to address unmet medical needs for patients globally. The company’s flagship technology, Electrical Nerve Block, targets the elimination of chronic pain associated with various conditions, including neuroma, residual limb pain, chronic post-surgical pain, and chronic migraines. Additionally, Neuros Medical offers the Neuros Altius System, which features an implantable generator with an integrated rechargeable battery, a cuff electrode, and external devices designed to enhance treatment outcomes. Founded in 2008, the company aims to provide innovative solutions for chronic pain management.

Okami Medical

Series B in 2017
Okami Medical, Inc. specializes in the manufacturing and supply of medical devices designed for the occlusion of peripheral vessels. The company's flagship product, the LOw-profile Braided Occluder (LOBO), provides interventional physicians with a versatile solution for occluding various arterial targets without the need for multiple embolic devices. The LOBO system features a patented design and proprietary HDBRAID technology, which creates a highly occlusive pore structure that effectively reduces blood flow and accelerates vessel closure. Founded in 2011 and headquartered in Aliso Viejo, California, Okami Medical was established to meet the evolving needs of patients and physicians by developing innovative and reliable medical devices for vessel occlusion.

Inceptus Medical

Series B in 2017
Inceptus Medical is a medical device company incubator based in Aliso Viejo, California, founded in 2011. The firm is dedicated to transforming innovative concepts into successful companies by leveraging a combination of experienced engineering, clinical research expertise, and seasoned leadership. Inceptus Medical's team comprises skilled medical device engineers, serial entrepreneurs, executive managers, and investors, all of whom have a proven track record in establishing medical device companies. The firm focuses on the medical devices sector, providing strong financial resources to support the development and commercialization of new technologies.

Effector Therapeutics

Series C in 2017
Effector Therapeutics is a biotechnology company based in San Diego, California, that specializes in the development of small molecule drugs aimed at treating cancer and other serious diseases. Founded in 2012, the company focuses on creating selective translation regulators that target the regulation of protein synthesis, a critical process in tumor growth and survival. By selectively blocking dysregulated translation, Effector Therapeutics aims to inhibit cancer cell proliferation while providing a potent and targeted therapeutic approach. This innovative strategy positions the company to potentially deliver new and effective treatments to patients facing challenging health conditions.

Primary

Series B in 2017
Primary is making better clothes for kids and building a better experience for busy parents to shop for them. It aims to be the most inclusive kid's clothing brand, offering high-quality essentials at affordable prices. Rather than chasing the trend, Primary offers thoughtfully designed clothing without logos, slogans, or sequins. They take a gender-neutral approach, with a broad range of colors available for babies and kids 0-12, without prescribing what is for girls or boys. It was founded in 2015 and is headquartered in New York, New York.

Entelo

Series C in 2017
Entelo applies intelligence to big data to help modern recruiters find, qualify, and acquire talent. Today over 600 customers of all sizes and industries trust Entelo to provide their talent acquisition teams with higher candidate engagement, actionable insights, and increased productivity. To learn how leading companies such as Capital One, Cisco, Facebook, GE, Genentech, Netflix, Northrop Grumman, and Target are building their organizations using Entelo, visit www.entelo.com.

Omada

Series C in 2017
Omada Health, Inc. is a digital healthcare company that creates online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health helps employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the needs of participants, including services for diabetes prevention and management, hypertension, behavioral health, and musculoskeletal issues. By integrating professional health coaching, connected devices, real-time data, and personalized feedback, Omada Health strives to empower individuals to engage with their health and achieve sustainable lifestyle changes. It is recognized as the largest provider of the National Diabetes Prevention Program by the CDC.

HelloSign

Series B in 2017
HelloSign is a technology company that provides fast, secure, and legally binding eSignature solutions, along with digital workflow and eFax services. The platform is designed to streamline business transactions for a diverse range of users, from small startups to large enterprises, making it easier to manage and automate important processes. Trusted by millions of individuals and over 60,000 companies worldwide, HelloSign prioritizes user experience and innovation in its mission to simplify work and improve efficiency in business operations.

Route 92

Venture Round in 2017
Route 92 Medical, Inc. specializes in developing innovative medical devices aimed at treating acute ischemic stroke and related conditions. The company has created a stealthy catheter, a rapid aspiration thrombectomy system, and an intra-cerebral implant delivery system. These products are designed to assist healthcare professionals in effectively treating strokes and enhancing patient recovery. Founded in 2015 and based in San Mateo, California, Route 92 Medical continues to focus on advancing technologies that improve outcomes for stroke patients.

Chute

Series B in 2017
Chute Corporation, founded in 2011 and based in San Francisco, specializes in visual marketing automation. The company offers a platform that enables marketers to discover, organize, and publish user-generated content, specifically fan photos and videos. This platform supports various touchpoints, including mobile apps, photo galleries, and advertising displays. Chute also provides a Capture app that allows brands to source real-time images from employees and ambassadors on iOS and Android devices. By leveraging visual recognition, geolocation, and text search, Chute empowers agencies, publishers, and brands to curate content while gaining valuable insights into consumer engagement and influencer effectiveness. Through its services, the company facilitates the collection of user data, enhancing marketing strategies and campaign effectiveness.

HotelTonight

Series E in 2017
HotelTonight, Inc. is a mobile application designed for booking same-day and last-minute hotel deals, allowing users to secure accommodations that would otherwise remain unsold. Founded in 2010 and based in San Francisco, the platform offers competitive pricing for last-minute bookings, catering to business travelers, leisure travelers, and locals alike. The application enables users to check room availability and access discounts on unsold hotel rooms, facilitating bookings for up to 100 days in advance in popular destinations. As of April 2019, HotelTonight operates as a subsidiary of Airbnb, enhancing its reach within the hospitality market.

Kenna Security

Series B in 2016
Kenna Security, Inc. is a technology company specializing in vulnerability management and risk intelligence solutions. Founded in 2009 and headquartered in San Francisco, with an additional office in Chicago, the company offers the Kenna platform, which enables organizations to prioritize vulnerabilities, measure risk, and automate analysis. By utilizing Cyber Risk Context Technology, Kenna helps clients focus on critical cyber risks, thereby enhancing the efficiency of security teams. Its solutions cater to a diverse range of sectors, including media and entertainment, healthcare, telecommunications, financial services, and more, both domestically and internationally. Kenna Security has established itself as a leader in predictive cyber risk management, serving numerous Fortune 100 companies across various industries.

Inspire Medical Systems

Series F in 2016
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.

Intuity Medical

Venture Round in 2016
Intuity Medical develops blood glucose monitoring systems for diabetes management. Their POGO Automatic Blood Glucose Monitoring System is the world’s first FDA-cleared automatic, one-step blood glucose meter that combines lancing, blood collection, and analysis into a single 10-test cartridge. It provides a convenient and discreet solution for millions of patients who need to regularly test their blood glucose. The company was founded in 2002 and is headquartered in Fremont, California.

Pluto TV

Series B in 2016
Pluto TV is a free streaming television service that offers over 100 live channels and a vast library of on-demand movies. Founded in 2013 and headquartered in Los Angeles, California, the platform partners with major television networks, movie studios, publishers, and digital media companies to provide a diverse range of content, including news, sports, lifestyle programming, cartoons, and trending digital series. Accessible via mobile apps, web browsers, and connected TV devices, Pluto TV attracts millions of viewers each month, making it a leading choice for free entertainment in the United States. As a subsidiary of Viacom International Inc., Pluto TV continues to expand its offerings and reach a broad audience.

SentreHEART

Series D in 2016
SentreHEART, Inc., based in Redwood City, California, is a privately held medical device company that manufacturers the LARIAT Suture Delivery Device for remote delivery of a pre-tied suture loop. Innovation in catheter and suture delivery technology enables physicians to remotely deliver a 40mm pre-tied suture loop for immediate and complete soft tissue closure through access as small as 4.3mm and with no metal, clips or fabrics left behind. Regulatory clearance for soft tissue ligation and approximation has been received in the US, Europe, and Canada.

Cato Networks

Series B in 2016
Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform, designed to offer secure, scalable connectivity for modern enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, the company delivers an integrated networking and security solution that connects various enterprise locations, users, and data. Its offerings include software-defined wide area networking (SD-WAN), WAN optimization, firewall services, secure web gateways, and threat protection. Cato's platform enables organizations to reduce costs associated with traditional MPLS networks, improve performance across global locations, and ensure secure internet access for mobile users and cloud applications. By converging networking and security into a cloud-native service, Cato Networks helps businesses streamline operations and enhance security in a distributed, mobile, and cloud-enabled environment. The company also has a presence in key global locations, including the United States, the United Kingdom, Singapore, Hong Kong, and Australia.

Electric Cloud

Series F in 2016
Electric Cloud, Inc. specializes in developing release automation and continuous delivery software for a diverse range of industries, including financial services, automotive, and embedded systems. Founded in 2002 and based in San Jose, California, the company offers products such as ElectricFlow, a release orchestration platform that enables teams to manage releases efficiently, and Electric Accelerator, which enhances build and testing processes by distributing workloads across various resources. Electric Cloud's solutions help organizations like Cisco, GE, and Intel improve their DevOps productivity and streamline their software delivery processes. By automating manual tasks and reducing the risks associated with software releases, the company empowers development teams to accelerate time-to-market and enhance software quality. As of April 2019, Electric Cloud operates as a subsidiary of CloudBees, Inc.

Cleave Therapeutics

Series B in 2016
Cleave Therapeutics, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2010. The company specializes in developing novel small-molecule drugs that target valosin-containing protein and other protein-degradation pathways critical for the survival of cancer cells. By focusing on these mechanisms, Cleave Therapeutics aims to create enzyme inhibitors that can effectively treat cancer and neurodegenerative diseases. Its research efforts are directed toward discovering innovative therapies that may improve patient outcomes in oncology.

Apptimize

Series B in 2016
Apptimize Inc. is a mobile A/B testing platform that assists developers of iOS and Android applications in optimizing user experience through real-time updates and actionable insights. Founded in 2013 and based in San Francisco, California, the company provides tools for cross-platform optimization across various channels, including web and mobile. Apptimize's platform enables mobile teams to enhance revenue and engagement by utilizing features such as A/B testing, feature flags, and analytics. By offering a testing framework that allows for code verification, the platform helps clients personalize user experiences and improve key performance metrics like conversion, engagement, and retention. Apptimize collaborates with notable brands such as the Wall Street Journal, Western Union, and Trulia. As of August 2019, Apptimize operates as a subsidiary of Airship, Inc.

Appthority

Series B in 2016
Appthority, Inc. specializes in mobile application security solutions, focusing on protecting enterprises from mobile threats that jeopardize data privacy and employee security. Founded in 2011 and based in San Francisco, California, Appthority has established itself as a leader in the Mobile Threat Defense sector. The company's flagship product, the Mobile Threat Protection (MTP) solution, provides comprehensive protection against risks associated with mobile devices, applications, and networks. Appthority is trusted by numerous Fortune 1000 companies for its ability to deliver effective mobile threat protection while offering enhanced visibility and control over mobile risks. As a subsidiary of NortonLifeLock Inc. since November 2018, Appthority continues to prioritize the security of enterprise data and the productivity of employees.

Primary

Series A in 2016
Primary is making better clothes for kids and building a better experience for busy parents to shop for them. It aims to be the most inclusive kid's clothing brand, offering high-quality essentials at affordable prices. Rather than chasing the trend, Primary offers thoughtfully designed clothing without logos, slogans, or sequins. They take a gender-neutral approach, with a broad range of colors available for babies and kids 0-12, without prescribing what is for girls or boys. It was founded in 2015 and is headquartered in New York, New York.

ZEFR

Series E in 2016
ZEFR is a video advertising company that specializes in creating targeted video ad placements using proprietary technology. The company offers custom packages that combine advanced technology with human oversight to select individual videos, ensuring that brands can scale their video ad campaigns safely and effectively. ZEFR has access to extensive data, surpassing that of any YouTube partner, which allows it to improve outcomes for content owners and brands alike. By aligning the right advertisements with relevant content on preferred platforms, ZEFR enhances audience engagement and optimizes advertising performance.

Ribon Therapeutics

Series A in 2016
Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, founded in 2015. The company is focused on developing innovative cancer therapies that target monoPARP proteins, which are essential regulators of cancer cell survival. Ribon's scientific founders have made significant contributions to the understanding of PARPs, or poly(ADP-ribose) polymerases, and their roles in cancer. Leveraging this expertise, Ribon is establishing a proprietary drug discovery platform aimed at exploring the molecular actions and biological functions of monoPARPs. This platform supports the creation of a pipeline of therapeutics that selectively target these proteins to potentially treat cancer and other diseases. Ribon Therapeutics is supported by notable life science investors, enhancing its capability to advance its research and development efforts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.